Intellia Therapeutics
Pioneer in CRISPR/Cas9-based gene editing therapeutics, developing in vivo and ex vivo treatments for genetic diseases, cancer, and autoimmune conditions. Publicly traded on NASDAQ (NTLA).
Website
https://www.intelliatx.comLocation
Cambridge, Massachusetts, USA
Founded
2014
Investors
1
Categories
therapeutics, biotech, gene-editing, crispr, public
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Atlas Venture | Cambridge, USA | biotech-focused | seedseries-a+1 | 1 |